The Claim
GLP-1 receptor expression in tumors such as insulinomas, pheochromocytomas, and brain tumors enables their use as molecular targets for in vivo scintigraphy and targeted radiotherapy due to high tumor expression and low background signal in surrounding normal tissues.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Some tumors have a special marker that might let doctors see them better on scans or treat them with targeted radiation, because the marker shows up strongly on the tumor but not in healthy tissue around it.
See the scientific wording
GLP-1 receptor expression in tumors such as insulinomas, pheochromocytomas, and brain tumors may enable their use as molecular targets for in vivo scintigraphy and targeted radiotherapy, due to high tumor expression and low background in surrounding normal tissues.
What the research says
1 studyStudy: GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
The study found that certain tumors have lots of GLP-1 receptors, while nearby healthy tissues have very few, which means doctors could potentially use them to target tumors with scans or radiation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.